Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
复制标题
DOI:
10.1159/000481269
复制
发表时间:
2017
影响因子:
4.2
通讯作者:
Tuttle KR
中科院分区:
文献类型:
--
作者:
Saulnier PJ;Dieter BP;Tanamas SK;McPherson SM;Wheelock KM;Knowler WC;Looker HC;Meek RL;Nelson RG;Tuttle KR
Serum amyloid A (SAA) induces inflammation and apoptosis in kidney cells and associates with pathologic changes of diabetic kidney disease (DKD). Higher serum SAA concentrations were previously associated with increased risk of end-stage renal disease (ESRD) and death in persons with type 2 diabetes and advanced DKD. We explored the prognostic value of SAA in American Indians with type 2 diabetes without DKD or with early DKD. SAA concentration was measured in serum samples obtained at the start of follow-up. Multivariate proportional hazards models were employed to examine the magnitude of the risk of ESRD or death across tertiles of SAA concentration after adjustment for traditional risk factors. The C statistic was used to assess the additional predictive value of SAA relative to traditional risk factors. Of 256 participants (mean ± SD glomerular filtration rate [iothalamate]=148±45 ml/min, and median [IQR] urine albumin/creatinine=39 [14–221] mg/g), 76 developed ESRD and 125 died during median follow-up of 15.2 and 15.7 years, respectively. After multivariable proportional hazards regression, participants in the two highest SAA tertiles combined exhibited a 53% lower risk of ESRD (Hazard Ratio [HR]=0.47, 95%CI 0.29–0.78), and a 30% lower risk of death (HR=0.70, 95%CI 0.48–1.02), compared with participants in the lowest SAA tertile, although the lower risk of death was not statistically significant. Addition of SAA to the ESRD model increased the C statistic from 0.814 to 0.815 (P=0.005). Higher circulating SAA concentration is associated with a reduced risk of ESRD in American Indians with type 2 diabetes.
登录
查看更多内容
影响因子:
13
作者:
De Buck M;Gouwy M;Wang JM;Van Snick J;Proost P;Struyf S;Van Damme J
通讯作者:
Van Damme J
影响因子:
8.2
作者:
Brosius FC;Tuttle KR;Kretzler M
通讯作者:
Kretzler M
影响因子:
2
作者:
Pencina, MJ;D'Agostino, RB
通讯作者:
D'Agostino, RB
影响因子:
6.1
作者:
Meek, Rick L.;LeBoeuf, Renee C.;Tuttle, Katherine R.
通讯作者:
Tuttle, Katherine R.
DOI:
10.4049/jimmunol.0901363
发表时间:
2009-07-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Bauernfeind FG;Horvath G;Stutz A;Alnemri ES;MacDonald K;Speert D;Fernandes-Alnemri T;Wu J;Monks BG;Fitzgerald KA;Hornung V;Latz E
通讯作者:
Latz E